Point-of-Care Glucose Testing Market 2024 - By Size, Share, Trends, Demand, Global Challenges, Competitive Growth And Outlook By 2033

The new report published by The Business Research Company, titled Point-of-Care Glucose Testing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the point-of-care glucose testing market size has grown strongly in recent years. It will grow from $4.63 billion in 2023 to $4.88 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

The Surge In Diabetes Propels Point-Of-Care Glucose Testing Market Growth
The growing prevalence of diabetes is expected to propel the growth of the point-of-care glucose testing market going forward. Diabetes is a chronic metabolic disorder that elevates blood glucose levels, leading over time to severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is a frequently used technology for determining glucose levels in hospitalized patients, facilitating prompt treatment decisions in response to glycemia changes, and enhancing therapeutic output and diabetes management. For instance, in 2022, the Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people have diabetes which equals 11.3% of the United States population in 2021. Further, in November 2021, according to the International Diabetes Federation, a Belgium-based diabetes federation, the global diabetic population is expected to increase from 643 million (11.3%) by 2030 to 783 million (12.2%) by 2045. Therefore, the growing prevalence of diabetes is driving the growth of the point-of-care glucose testing market.

Product Innovation In Point-Of-Care Glucose Testing
Product innovation is the key trend gaining popularity in the point-of-care glucose testing market. Major companies operating in the point-of-care glucose testing market are focused on developing innovative products to strengthen their position in the market. For instance, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced Cobas Pulse, a new point-of-care blood glucose monitor for healthcare staff. It will accompany a companion gadget styled like a touchscreen smartphone running its apps. Cobas pulse is a hand-held device with an automated glucose test strip reader, camera, and touchscreen that enables documenting diagnostic data and is housed in a rugged housing that can be disinfected and used in patients of all age groups, including newborns and intensive care. Additionally, it seeks to improve physicians' workflow by running the Glucommander dosage software on the blood glucose reader and adding downloadable decision-support apps from businesses such as Smart4Diagnostics, CardioSignal, and SteadySense.

The point-of-care glucose testing market covered in this report is segmented -

1) By Product: Lancet And Lancing Devices, Strips, Meters
2) By Testing Site: Fingertips, Alternate Site Testing
3) By Applications: Type-1 Diabetes, Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12207&type=discount

Major companies operating in the point-of-care glucose testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Bluedrop Medical Limited

Contents of the report:
1. Executive Summary
2. Point-of-Care Glucose Testing Market Report Structure
3. Point-of-Care Glucose Testing Market Trends And Strategies
4. Point-of-Care Glucose Testing Market - Macro Economic Scenario
5. Point-of-Care Glucose Testing Market Size And Growth
…..
27. Point-of-Care Glucose Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.